Impact of the Medicaid Drug Rebate Program on Expenditures, Utilization andAccess

摘要

The overall purpose of this project was to assess the implementation and netimpact of the Medicaid drug rebate legislation on access to, utilization of, and expenditures for prescribed drugs for the Medicaid population. The impact of changes in drug restrictions such as formularies and prior authorization programs and changes in manufacturers drug prices were analyzed. Aggregate analysis of total Medicaid drug expenditures and rebates is reported by State and in the aggregate State cases studies analyzed the changes in drug expenditures before and after the Medicaid rebate program was implemented. The costs associate with administering the rebate program were obturned. Rebates constituted more than 18% of total prescribed drug expenditures in 1993. The greatest independent effect on total drug expenditures was due to enrollment increases. The cost of the rebate program are minimal as a percentage of the collected amonts, less than 1%.